• Xeris Biopharma named CEO John Shannon chair of the board, effective July 1, 2026.
• Marla Persky stepped down as chair, remaining on the board as lead independent director from July 1, 2026.
• Nerissa Kreher joined the board on July 1, 2026, expanding it to eight members.
• Kreher is chief medical officer at Alltrna; previously held CMO roles at Entrada Therapeutics, Tiburio Therapeutics, AVROBIO.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Xeris Biopharma Holdings Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260630562464) on June 30, 2026, and is solely responsible for the information contained therein.